We are focusing on the mechanisms of Egr protein action in three main areas:
I. Regulation of muscle stretch receptor development. In work pioneered by our laboratory, we found that Egr3 is upregulated in a small number of muscle cells after they are innervated by sensory axons during muscle development. The sensory axon contacted myotubes are fate specified by Egr3 to become muscle spindle stretch receptors that are necessary for normal stretch reflexes and coordinated limb movements. We are currently using a variety of contemporary molecular-genetic techniques including microarray analysis, recombinant virus mediated gene transfer and transgenic mouse models to understand the repertoire of target genes regulated by Egr3 and its role stretch receptor fate specification.
II. Sympathetic nervous system development. The sympathetic nervous system is critical for organ and tissue homeostasis. Sympathetic neurons depend upon target tissue derived growth factors such as nerve growth factor (NGF) for survival during development. Egr genes are regulated in sympathetic neurons by NGF and other growth factor signaling and accordingly, Egr-gene deficient mice have prominent defects in sympathetic nervous system development. We are characterizing the role of Egr genes in sympathetic nervous system development using Egr gene deficient mice, novel transgenic reporter mice and microarray studies to characterize target genes regulated by Egr proteins.
III. Role in learning and memory processing. Egr transcription factors are regulated by synaptic activity and Egr1 is widely recognized to be involved in gene regulation required for learning and memory. We are characterizing the role of other Egr transcription factors in learning and memory using a variety of novel gain-of-function and conditional loss-of-function mutant mice and characterizing their behavior in learning and memory. We are examining the role of a variety of potential target genes regulated by Egr proteins in learning and memory.
The lab is currently expanding investigation into studies revolving around the IKAP protein, also known as ELP1:
I. Sympathetic and sensory nervous system development. Tissue-specific reduction of IKAP in the nervous system has been implicated in the etiology of Familial Dysautonomia (FD; Riley-Day Syndrome; HSAN3, OMIM 223900). FD is characterized by the poor development and survival of sensory and autonomic neurons, but little is known regarding the specific functioning of this protein in vivo. We hope to gain insight into the precise role of IKAP in these contexts by using a variety of molecular and genetic techniques, including the generation of a novel, conditional knockout (cKO) mouse model of the disease.